Developer docs
API playgroundTry for free, no card

Search company profiles

Hyperfine

Full company profile

uuid0000kck

Namestring
Hyperfine
Legal namestring
Hyperfine, Inc.
Websiteurl
hyperfine.io
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Hyperfine, Inc. is a publicly traded medical technology company (NASDAQ: HYPR) headquartered in Guilford, Connecticut that developed the Swoop system, the world's first FDA-cleared portable ultra-low-field (0.064T) brain MRI system. The company's core technology pairs a miniaturized 0.064T magnet with Optive AI, a deep learning image reconstruction software that compensates for the inherently lower signal-to-noise ratio of ultra-low-field MRI to produce diagnostic-quality brain images. The Swoop system can be plugged into a standard outlet and operated in minutes by a trained clinician without requiring a dedicated MRI room, specialized technician, or fixed infrastructure, enabling point-of-care imaging in hospital ICU/ED settings, outpatient neurology clinics, pediatric facilities, and resource-constrained environments in low- and middle-income countries.

The product portfolio includes the original Swoop system (FDA-cleared 2020), the next-generation Swoop system (FDA-cleared Q2 2025 with CE Mark and UKCA approval in April 2026), and the Optive AI software platform with multiple iterative FDA clearances including a December 2025 multi-direction diffusion-weighted imaging update for enhanced stroke detection. Hyperfine generates revenue primarily through one-time hardware sales of the Swoop system, with pricing conducted on a quote-based enterprise model; pricing is not publicly disclosed. Go-to-market combines a direct enterprise sales force targeting US hospitals and neurology clinics with a distributor network spanning more than a dozen international markets, including exclusive partnerships with Radiosurgery Global (India) and Lioness Medtech (Nordics). Selected customers include Jefferson Abington Hospital (the highest-volume US site with 1,000+ scans), CHRISTUS Mother Frances, Atlantic Health's Morristown Medical Center, Neurology of Central Florida, and AIIMS New Delhi. Reported revenue was $13.56 million in FY2025 (5.2% YoY growth), with Q1 2026 revenue of $3.90 million (+83% YoY), FY2026 guidance of $20-22 million (~55% growth at midpoint), and gross margins improving to 51% in Q1 2026 from 41% in the prior-year quarter. Capital structure includes approximately $35 million in cash as of December 2025, a $40 million debt facility from Horizon Technology Finance (March 2026) extending runway into 2028, and two post-IPO equity raises in 2025 totaling $23.5 million.

Short descriptiontext

Hyperfine develops and commercializes the Swoop portable ultra-low-field (0.064T) brain MRI system and Optive AI image reconstruction software, serving hospitals, neurology clinics, and pediatric settings with point-of-care diagnostic imaging.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGuilford, United States
HQ citystring
Guilford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
portable MRI systems, brain imaging devices, point-of-care MRI, AI medical imaging, ultra-low-field MRI
Industry5 codes
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Swoop System Sales
TypeHardware Sales
Description

Sale of the Swoop portable MRI system to healthcare institutions including hospitals, neurology clinics, and pediatric facilities. Revenue is recognized upon system delivery and installation.

businesswire.com
2Optive AI Software
TypeHardware Sales
Description

AI-powered image reconstruction software integrated with the Swoop system, enabling advanced imaging capabilities and diagnostic quality at ultra-low field strengths.

hyperfinemri.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Swoop System - Base Configuration
ModelOne time/ perpetual license
Notes

Pricing not publicly disclosed. Quote-based enterprise sales model typical for medical device capital equipment.

hyperfinemri.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Swoop
Description

AI-powered portable MR imaging system for point-of-care brain imaging

hyperfinemri.com
+2 more records
Core offering1 text field

Hyperfine designs, manufactures, and sells the Swoop Portable MR Imaging System, an AI-powered, FDA-cleared ultra-low-field (0.064 Tesla) brain MRI that can be wheeled to the point of care in hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure or specialized technicians. The system is powered by Optive AI software, which uses deep-learning image reconstruction to reduce noise and blur and produce diagnostic-quality brain imaging at very low field strength. Revenue is generated through one-time capital equipment sales of the Swoop hardware system, with companion Optive AI software delivering advanced imaging sequences including T1, T2, FLAIR, and multi-direction diffusion-weighted imaging.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced median time from imaging order to scan start from 7.76 hours to 1.28 hours in emergency department settings (6.35 hour difference)
+4 more records
Product overview1 text field

Hyperfine offers a unified portable MRI portfolio centered on the Swoop system, an AI-powered portable brain MRI device that uses ultra-low-field (0.064T) technology and can be deployed at the point of care across hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure. The system is powered by Optive AI software, which provides deep learning-based image reconstruction to enhance image clarity. The product line includes the original Swoop system and the next-generation Swoop system (with improved image quality, workflow, and user experience). The system supports multiple imaging sequences including T1, T2, FLAIR, and diffusion-weighted imaging (DWI), with the latest Optive AI software update adding multi-direction DWI capabilities for enhanced stroke detection.

Product and service3 records
1Swoop Portable MR Imaging System
CategoryPortable MRI Hardware System
Description

AI-powered, FDA-cleared portable brain MRI system using ultra-low-field (0.064 Tesla) technology that can be wheeled to the point of care in hospitals (ICU, emergency department), neurology clinics, and pediatric settings without requiring dedicated MRI infrastructure, shielded rooms, or specialized MRI technicians. The system plugs into a standard outlet, sets up in minutes, and operates with an intuitive interface usable by trained healthcare professionals. Supports T1, T2, FLAIR, DWI, and multi-direction diffusion-weighted imaging sequences in axial, coronal, and sagittal planes.

2Optive AI Software
CategoryAI Medical Imaging Software
Description

AI-driven image reconstruction software powering the Swoop system, using deep learning to reduce noise and blur and enhance image clarity and consistency at ultra-low-field (0.064T) strength. Delivers sharper anatomical detail to support confident diagnoses at the point of care and includes multi-direction diffusion-weighted imaging for enhanced stroke detection.

3Next-Generation Swoop System
CategoryPortable MRI Hardware System
Description

Upgraded version of the Swoop portable MRI system with substantial improvements in image quality, workflow, and user experience. FDA-cleared in Q2 2025 and CE Mark/UKCA-approved in April 2026 for international commercialization across Europe, the UK, and other markets through the existing distributor network spanning over a dozen countries.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-10
Description

Exclusive Nordic distributor for Swoop portable MRI system. Participation in Akutveckan 2026 medical conference in Stockholm to showcase the system. First clinical systems being introduced in the Nordic region.

2Radiosurgery Global Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-20
Description

Exclusive Indian distributor partnership for Swoop portable MRI system. Enabled regulatory approval from India CDSCO and deployment at AIIMS New Delhi as first Indian hospital to deploy bedside brain imaging.

investing.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-19
Description

Lead institution for UNITY project, coordinating activities across 40+ academic and clinical centers in multiple countries. Project developing AI pipelines to improve image quality and diagnostic reliability for neonatal patients using Hyperfine's Swoop system.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the world's largest MRI manufacturers with deep hospital relationships and a broad imaging portfolio. While not focused exclusively on portable MRI, GE HealthCare is the most likely incumbent to launch a competing point-of-care brain MRI solution given its scale and R&D resources.

TypeBroad incumbent
Description

Global MRI market leader with MAGNETOM product family and extensive hospital installed base. Siemens has the engineering depth to enter portable/point-of-care MRI and would represent the most formidable competitive threat to Hyperfine's niche.

TypeBroad incumbent
Description

Major MRI manufacturer with strong neurology and critical care positioning. Philips' strength in integrated diagnostic workflows and ICU/ED solutions makes it a direct strategic competitor in the point-of-care imaging space Hyperfine is targeting.

TypeDirect peer
Description

Subsidiary of Samsung Electronics that pioneered portable CT scanners (BodyTom, OmniTom) for point-of-care neuroimaging. Most directly comparable peer given its focus on bringing imaging to the bedside in critical care settings, though in CT rather than MRI.

TypeBroad incumbent
Description

Established MRI manufacturer with Vantage Galan and other 1.5T/3T systems serving hospital radiology departments. Canon has the installed base and clinical relationships to expand into portable imaging if the market develops.

TypeEmerging player
Description

Publicly traded handheld ultrasound company using semiconductor-based probe technology and AI for image interpretation. Highly comparable go-to-market motion targeting point-of-care diagnosis with affordable, portable AI-enabled imaging, though in ultrasound rather than MRI.

TypeBroad incumbent
Description

Diversified imaging manufacturer with MRI systems and growing point-of-care portfolio. Fujifilm's expansion into portable diagnostics and AI-assisted imaging makes it a relevant competitive and adjacent technology peer.

TypeEmerging player
Description

Developer of handheld ultrasound with AI for point-of-care use. While in a different modality, Exo represents a parallel disruptive play in portable AI-enabled imaging targeting similar clinical use cases and care settings as Hyperfine.

TypeBroad incumbent
Description

Chinese-based global MRI manufacturer rapidly expanding in international markets, particularly emerging economies. Represents both a potential competitor and parallel player in democratizing MRI access globally.

10Tempus AI
TypeOthers
Description

AI-enabled healthcare technology company with imaging analytics and radiology AI capabilities. While not a hardware competitor, Tempus AI represents an adjacent player building AI infrastructure for medical imaging that could partner with or compete against Hyperfine's Optive AI software layer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors20 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hyperfine

Medical Imaging Equipmenthyperfine.io

Hyperfine develops and commercializes the Swoop portable ultra-low-field (0.064T) brain MRI system and Optive AI image reconstruction software, serving hospitals, neurology clinics, and pediatric settings with point-of-care diagnostic imaging.

What Hyperfine does

Hyperfine, Inc. is a publicly traded medical technology company (NASDAQ: HYPR) headquartered in Guilford, Connecticut that developed the Swoop system, the world's first FDA-cleared portable ultra-low-field (0.064T) brain MRI system. The company's core technology pairs a miniaturized 0.064T magnet with Optive AI, a deep learning image reconstruction software that compensates for the inherently lower signal-to-noise ratio of ultra-low-field MRI to produce diagnostic-quality brain images. The Swoop system can be plugged into a standard outlet and operated in minutes by a trained clinician without requiring a dedicated MRI room, specialized technician, or fixed infrastructure, enabling point-of-care imaging in hospital ICU/ED settings, outpatient neurology clinics, pediatric facilities, and resource-constrained environments in low- and middle-income countries.

The product portfolio includes the original Swoop system (FDA-cleared 2020), the next-generation Swoop system (FDA-cleared Q2 2025 with CE Mark and UKCA approval in April 2026), and the Optive AI software platform with multiple iterative FDA clearances including a December 2025 multi-direction diffusion-weighted imaging update for enhanced stroke detection. Hyperfine generates revenue primarily through one-time hardware sales of the Swoop system, with pricing conducted on a quote-based enterprise model; pricing is not publicly disclosed. Go-to-market combines a direct enterprise sales force targeting US hospitals and neurology clinics with a distributor network spanning more than a dozen international markets, including exclusive partnerships with Radiosurgery Global (India) and Lioness Medtech (Nordics). Selected customers include Jefferson Abington Hospital (the highest-volume US site with 1,000+ scans), CHRISTUS Mother Frances, Atlantic Health's Morristown Medical Center, Neurology of Central Florida, and AIIMS New Delhi. Reported revenue was $13.56 million in FY2025 (5.2% YoY growth), with Q1 2026 revenue of $3.90 million (+83% YoY), FY2026 guidance of $20-22 million (~55% growth at midpoint), and gross margins improving to 51% in Q1 2026 from 41% in the prior-year quarter. Capital structure includes approximately $35 million in cash as of December 2025, a $40 million debt facility from Horizon Technology Finance (March 2026) extending runway into 2028, and two post-IPO equity raises in 2025 totaling $23.5 million.

Hyperfine firmographics

Firmographics
Name
Hyperfine
Legal name
Hyperfine, Inc.
Website
https://hyperfine.io
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
101–250 employees
Short description
Hyperfine develops and commercializes the Swoop portable ultra-low-field (0.064T) brain MRI system and Optive AI image reconstruction software, serving hospitals, neurology clinics, and pediatric settings with point-of-care diagnostic imaging.
Ownership category
akta.pro rank

Hyperfine industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Diagnostic Imaging Centers (621512), Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability

Keywords

  • Portable MRI systems
  • Brain imaging devices
  • Point-of-care MRI
  • AI medical imaging
  • Ultra-low-field MRI

Where Hyperfine is headquartered

Location

Headquarters

HQ city
Guilford
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hyperfine business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Swoop System Sales: Sale of the Swoop portable MRI system to healthcare institutions including hospitals, neurology clinics, and pediatric facilities. Revenue is recognized upon system delivery and installation.
  2. Optive AI Software: AI-powered image reconstruction software integrated with the Swoop system, enabling advanced imaging capabilities and diagnostic quality at ultra-low field strengths.

Pricing tiers

ModelBillingPrice
One time/ perpetual license—Swoop System - Base Configuration

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Hyperfine product offering

Product offering

Core offering

Hyperfine designs, manufactures, and sells the Swoop Portable MR Imaging System, an AI-powered, FDA-cleared ultra-low-field (0.064 Tesla) brain MRI that can be wheeled to the point of care in hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure or specialized technicians. The system is powered by Optive AI software, which uses deep-learning image reconstruction to reduce noise and blur and produce diagnostic-quality brain imaging at very low field strength. Revenue is generated through one-time capital equipment sales of the Swoop hardware system, with companion Optive AI software delivering advanced imaging sequences including T1, T2, FLAIR, and multi-direction diffusion-weighted imaging.

Product overview

Hyperfine offers a unified portable MRI portfolio centered on the Swoop system, an AI-powered portable brain MRI device that uses ultra-low-field (0.064T) technology and can be deployed at the point of care across hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure. The system is powered by Optive AI software, which provides deep learning-based image reconstruction to enhance image clarity. The product line includes the original Swoop system and the next-generation Swoop system (with improved image quality, workflow, and user experience). The system supports multiple imaging sequences including T1, T2, FLAIR, and diffusion-weighted imaging (DWI), with the latest Optive AI software update adding multi-direction DWI capabilities for enhanced stroke detection.

Differentiator

Problem solved

Functional benefit

Brands

  • Swoop: AI-powered portable MR imaging system for point-of-care brain imaging
  • Optive AI
  • Portable MR Imaging

Products and services

  • Swoop Portable MR Imaging System AI-powered, FDA-cleared portable brain MRI system using ultra-low-field (0.064 Tesla) technology that can be wheeled to the point of care in hospitals (ICU, emergency department), neurology clinics, and pediatric settings without requiring dedicated MRI infrastructure, shielded rooms, or specialized MRI technicians. The system plugs into a standard outlet, sets up in minutes, and operates with an intuitive interface usable by trained healthcare professionals. Supports T1, T2, FLAIR, DWI, and multi-direction diffusion-weighted imaging sequences in axial, coronal, and sagittal planes.
  • Optive AI Software AI-driven image reconstruction software powering the Swoop system, using deep learning to reduce noise and blur and enhance image clarity and consistency at ultra-low-field (0.064T) strength. Delivers sharper anatomical detail to support confident diagnoses at the point of care and includes multi-direction diffusion-weighted imaging for enhanced stroke detection.
  • Next-Generation Swoop System Upgraded version of the Swoop portable MRI system with substantial improvements in image quality, workflow, and user experience. FDA-cleared in Q2 2025 and CE Mark/UKCA-approved in April 2026 for international commercialization across Europe, the UK, and other markets through the existing distributor network spanning over a dozen countries.

Quantifiable outcome

  • Reduced median time from imaging order to scan start from 7.76 hours to 1.28 hours in emergency department settings (6.35 hour difference)
  • +4 more outcomes

Companies that use Hyperfine

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Hyperfine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Hyperfine partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered regional and core.

  • Lioness Medtech ABregionalChannel Partner/ Reseller/ Distributor · 10 March 2026Exclusive Nordic distributor for Swoop portable MRI system. Participation in Akutveckan 2026 medical conference in Stockholm to showcase the system. First clinical systems being introduced in the Nordic region.
  • Radiosurgery Global Ltd.coreChannel Partner/ Reseller/ Distributor · 20 January 2026Exclusive Indian distributor partnership for Swoop portable MRI system. Enabled regulatory approval from India CDSCO and deployment at AIIMS New Delhi as first Indian hospital to deploy bedside brain imaging.
  • King's College LondoncoreStrategic or Co-development Partner · 19 November 2025Lead institution for UNITY project, coordinating activities across 40+ academic and clinical centers in multiple countries. Project developing AI pipelines to improve image quality and diagnostic reliability for neonatal patients using Hyperfine's Swoop system.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Hyperfine competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: One of the world's largest MRI manufacturers with deep hospital relationships and a broad imaging portfolio. While not focused exclusively on portable MRI, GE HealthCare is the most likely incumbent to launch a competing point-of-care brain MRI solution given its scale and R&D resources.
  • Siemens Healthineers: Global MRI market leader with MAGNETOM product family and extensive hospital installed base. Siemens has the engineering depth to enter portable/point-of-care MRI and would represent the most formidable competitive threat to Hyperfine's niche.
  • Philips Healthcare: Major MRI manufacturer with strong neurology and critical care positioning. Philips' strength in integrated diagnostic workflows and ICU/ED solutions makes it a direct strategic competitor in the point-of-care imaging space Hyperfine is targeting.
  • Canon Medical Systems: Established MRI manufacturer with Vantage Galan and other 1.5T/3T systems serving hospital radiology departments. Canon has the installed base and clinical relationships to expand into portable imaging if the market develops.
  • Fujifilm Healthcare: Diversified imaging manufacturer with MRI systems and growing point-of-care portfolio. Fujifilm's expansion into portable diagnostics and AI-assisted imaging makes it a relevant competitive and adjacent technology peer.
  • United Imaging Healthcare: Chinese-based global MRI manufacturer rapidly expanding in international markets, particularly emerging economies. Represents both a potential competitor and parallel player in democratizing MRI access globally.

Direct peers

  • Samsung Neurologica: Subsidiary of Samsung Electronics that pioneered portable CT scanners (BodyTom, OmniTom) for point-of-care neuroimaging. Most directly comparable peer given its focus on bringing imaging to the bedside in critical care settings, though in CT rather than MRI.

Emerging players

  • Butterfly Network: Publicly traded handheld ultrasound company using semiconductor-based probe technology and AI for image interpretation. Highly comparable go-to-market motion targeting point-of-care diagnosis with affordable, portable AI-enabled imaging, though in ultrasound rather than MRI.
  • Exo Imaging: Developer of handheld ultrasound with AI for point-of-care use. While in a different modality, Exo represents a parallel disruptive play in portable AI-enabled imaging targeting similar clinical use cases and care settings as Hyperfine.

Others

  • Tempus AI: AI-enabled healthcare technology company with imaging analytics and radiology AI capabilities. While not a hardware competitor, Tempus AI represents an adjacent player building AI infrastructure for medical imaging that could partner with or compete against Hyperfine's Optive AI software layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hyperfine social profiles

Digital presence

Hyperfine compliance and trust

Trust signal

Compliance4 records

Hyperfine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hyperfine leadership team

Management profile

Number of profiles

Profiles17 records

Hyperfine funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors20 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hyperfine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyperfine

What does Hyperfine do?

Hyperfine designs, manufactures, and sells the Swoop Portable MR Imaging System, an AI-powered, FDA-cleared ultra-low-field (0.064 Tesla) brain MRI that can be wheeled to the point of care in hospitals, neurology clinics, and pediatric settings without dedicated MRI infrastructure or specialized technicians. The system is powered by Optive AI software, which uses deep-learning image reconstruction to reduce noise and blur and produce diagnostic-quality brain imaging at very low field strength. Revenue is generated through one-time capital equipment sales of the Swoop hardware system, with companion Optive AI software delivering advanced imaging sequences including T1, T2, FLAIR, and multi-direction diffusion-weighted imaging.

Is Hyperfine a public or private company?

Hyperfine is a public company. It is classified as public and is currently operating.

When was Hyperfine founded?

Hyperfine was founded in 2014. It employs 101 to 250 people.

Where is Hyperfine based?

Hyperfine is headquartered in Guilford, United States, in the North America region.

How does Hyperfine make money?

Two revenue lines are on record. Swoop System Sales are the primary driver. The others are optive AI Software.

Who are Hyperfine's main competitors?

Broad incumbents on record are GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Healthcare and United Imaging Healthcare. Samsung Neurologica is listed as a direct peer. Emerging players are Butterfly Network and Exo Imaging. Tempus AI is listed as an others.

Does Hyperfine have an API?

No public API is recorded for Hyperfine.

What industry is Hyperfine in?

Hyperfine's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems, with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 621512 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooHyperfine Inc (HYPR) Q3 2026 Earnings Call Highlights: Record Revenue, 73% Growth, and First ...Hyperfine Inc reported record Q3 2026 revenue of $6.0 million, up 73% year over year, with net cash burn of $5.6 million, down 29% sequentially. The company reaffirmed full-year 2026 revenue guidance of $20-22 million and raised its gross margin low end to 52.5%. It expects contrast 510(k) submission by year-end 2026.Business Wire BlogHyperfine, Inc. Reports Third Quarter 2026 Financial ResultsHyperfine reported Q3 2026 revenue of $6.0 million, up 73% year-over-year, with a record gross profit of $3.4 million and a 57% gross margin. Net loss was $6.0 million, and net cash burn fell to $5.6 million, the lowest quarterly burn, with revenue exceeding burn for the first time. Management guided full-year 2026 revenue to $20–22 million.Stock TitanHyperfine, Inc. Reports Third Quarter 2026 Financial ResultsHyperfine reported Q3 2026 revenue of $6.0 million, up 73% year-over-year, with a record gross profit of $3.4 million and a 57% gross margin. The company posted a net loss of $6.0 million, its narrowest quarterly loss, and net cash burn of $5.6 million, the lowest on record. Management guided full-year 2026 revenue to $20–22 million and net cash burn to $26–28 million.American Banking and Market NewsHyperfine (NASDAQ:HYPR) Downgraded by Wall Street Zen to “Sell”Wall Street Zen downgraded Hyperfine from 'hold' to 'sell' on Sunday. The stock opened at $0.72, with an average analyst rating of 'Moderate Buy' and a $2.02 target. Hyperfine reported a loss of $0.09 per share for the quarter, missing revenue estimates.Defense WorldSysmex (OTCMKTS:SSMXY) vs. Hyperfine (NASDAQ:HYPR) Critical AnalysisA comparison of Hyperfine and Sysmex evaluates profitability, valuation, and analyst ratings. Hyperfine beats Sysmex on 8 of 15 factors, with a consensus target price of $2.02 implying 195.45% upside. Hyperfine is more volatile (beta 1.49) than Sysmex (beta 1.2).American Banking and Market NewsNephros (NASDAQ:NEPH) & Hyperfine (NASDAQ:HYPR) Critical ContrastNephros and Hyperfine are compared on profitability, risk, ownership, and analyst ratings. Nephros beats Hyperfine on 9 of 15 factors, with higher revenue and earnings, but Hyperfine has a stronger consensus rating and higher upside. Analysts favor Hyperfine despite Nephros's better fundamentals.MarketBeatHyperfine, Inc. (NASDAQ:HYPR) Stock Has Average Price Target of $2.02Analysts rate Hyperfine, Inc. a Moderate Buy with an average 1-year price target of $2.02. Institutional investors hold 15.03% of the stock, and the company reported a loss of $0.09 per share for the quarter. The stock opened at $0.72 on Friday.MarketBeatHyperfine (NASDAQ:HYPR) Cut to "Sell" at Wall Street ZenWall Street Zen downgraded Hyperfine from 'hold' to 'sell' on Saturday. The stock opened at $0.72, with a consensus price target of $2.02 and a Moderate Buy rating. Analysts expect a loss of $0.34 per share for the current year.American Banking and Market NewsHyperfine (NASDAQ:HYPR) Stock Rating Lowered by Wall Street ZenWall Street Zen downgraded Hyperfine from hold to sell. The stock opened at $0.72, with a consensus rating of Moderate Buy and an average price target of $2.02. Analysts forecast a fiscal-year loss of $0.34 per share.TradingViewHyperfine, Inc. (HYPR) Secures CE Mark and UKCA for Optive AI UpdateHyperfine received CE and UKCA approval for its Optive AI update for the Swoop Model 2 portable brain MRI, enabling enhanced image quality and workflow. The update adds a new isotropic T1 sequence, expanding clinical utility in surgical and clinic settings.